Trials / Completed
CompletedNCT04170140
Study on Prescribers' Knowledge and Understanding of Safety Messages Following Dengvaxia® Product Information Update
A Cross-sectional Survey to Evaluate Prescribers' Knowledge and Understanding of Safety Messages Following Dengvaxia® Product Information Update
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (actual)
- Sponsor
- Sanofi Pasteur, a Sanofi Company · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
The primary objective of the study is to evaluate the effectiveness of additional risk minimization measures material by assessing the knowledge and understanding of healthcare professionals regarding the key safety messages provided in the material. The secondary objective of the study is to evaluate if healthcare professionals know Dengvaxia product information, namely, age indication and contraindications.
Detailed description
The study is a cross-sectional Survey. Study data are collected through a questionnaire.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention | Questionnaire |
Timeline
- Start date
- 2020-01-07
- Primary completion
- 2020-03-05
- Completion
- 2020-03-05
- First posted
- 2019-11-20
- Last updated
- 2023-09-18
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04170140. Inclusion in this directory is not an endorsement.